Delivery Order SPE2DB20D3101-SPE2DB24FRAT1
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $5,612.18 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,401,649 units of ondansetron ODT 8 mg tablets. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a $14,550.99 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division. The order is for the supply of 4,564,299,405 units of the pharmaceutical product Ondansetron ODT 8 mg Tablets. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. The IDC enables DLA to efficiently procure essential...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,517.44 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of 4,563,534,937 units of Ondansetron HCL 8 mg tablets, with a completion date of February 5, 2024. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract valued at $12,751.76 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the supply of 4,564,990,448 units of ondansetron ODT 4 mg tablets to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing...
- The Defense Logistics Agency (DLA) awarded a $20,918.00 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division for the supply of 4,565,862,861 units of Ondansetron HCL 8 mg tablets. This order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to support...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $6,874.12 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,144,293 units of Ondansetron ODT 4 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which serves as the primary contract vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,528.76 contract is for the supply of 4,564,885,759 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, with an ultimate completion date of June 13, 2024. Amerisourcebergen, a large pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $3,582.60 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is to provide 4,564,221,918 units of the pharmaceutical product Ondansetron ODT 8 mg tablets in 30-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office division. The $19,006.49 contract is for the provision of 4,565,032,100 units of the pharmaceutical product Ondansetron ODT 4 mg tablets. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a...
- The U.S. government agency Defense Logistics Agency (DLA) awarded a $12,102.52 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,287,347 units of Ondansetron ODT 8 mg Tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FRAT1Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,686.75 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,563,557,459 units of Ondansetron ODT 8 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999.00, which runs through November 2026. The contract is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen's parent company is Cencora, Inc., which also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 2/5/24 |